Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Morton

Showing results (881-890 of 1,110) with videos related to

Pageof 111
Sort By:
Nephrology (Carlton, Vic.)|February 11, 2016
Advance care planning in chronic kidney disease: A survey of current practice in AustraliaTim Luckett, Lucy Spencer, Rachael L Morton, et al.
Journal of Pediatric Surgery|January 3, 2025
Characterizing Sensitivity to Vincristine, Irinotecan, and Telomerase-targeted Therapy in Diffuse Anaplastic Wilms Tumor Patient-derived Xenografts<sup>☆</sup>Daniel B Gehle, Carolyn M Jablonowski, Prahalathan Pichavaram, et al.
BMJ Open|November 6, 2020
Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocolMbathio Dieng, Nikita Khanna, Mai Thi Hoang Nguyen, et al.
Transplantation Direct|April 24, 2023
Cost-effectiveness of Interventions to Increase Utilization of Kidneys From Deceased Donors With Primary Brain Malignancy in an Australian SettingJames A Hedley, Patrick J Kelly, Melanie Wyld, et al.
Cancer Epidemiology|May 19, 2019
Risk attitudes and sun protection behaviour: Can behaviour be altered by using a melanoma genomic risk intervention?Rachael L Morton, Rebecca Asher, Edward Peyton, et al.
BMC Cancer|April 19, 2011
Whole brain radiotherapy after local treatment of brain metastases in melanoma patients--a randomised phase III trialGerald Fogarty, Rachael L Morton, Janette Vardy, et al.
Pediatric Blood & Cancer|February 19, 2010
Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing ProgramPeter J Houghton, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|June 29, 2010
Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing programChristopher L Morton, Peter J Houghton, E Anders Kolb, et al.
Cancer Epidemiology|October 1, 2016
Doctors' recognition and management of melanoma patients' risk: An Australian population-based studyC M Madronio, B K Armstrong, C G Watts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Psychoeducational Intervention to Reduce Fear of Cancer Recurrence in People at High Risk of Developing Another Primary Melanoma: Results of a Randomized Controlled TrialMbathio Dieng, Phyllis N Butow, Daniel S J Costa, et al.
Pageof 111

Showing results (881-890 of 1,110) with videos related to

Sort By:
Pageof 111
Nephrology (Carlton, Vic.)|February 11, 2016
Advance care planning in chronic kidney disease: A survey of current practice in AustraliaTim Luckett, Lucy Spencer, Rachael L Morton, et al.
Journal of Pediatric Surgery|January 3, 2025
Characterizing Sensitivity to Vincristine, Irinotecan, and Telomerase-targeted Therapy in Diffuse Anaplastic Wilms Tumor Patient-derived Xenografts<sup>☆</sup>Daniel B Gehle, Carolyn M Jablonowski, Prahalathan Pichavaram, et al.
BMJ Open|November 6, 2020
Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocolMbathio Dieng, Nikita Khanna, Mai Thi Hoang Nguyen, et al.
Transplantation Direct|April 24, 2023
Cost-effectiveness of Interventions to Increase Utilization of Kidneys From Deceased Donors With Primary Brain Malignancy in an Australian SettingJames A Hedley, Patrick J Kelly, Melanie Wyld, et al.
Cancer Epidemiology|May 19, 2019
Risk attitudes and sun protection behaviour: Can behaviour be altered by using a melanoma genomic risk intervention?Rachael L Morton, Rebecca Asher, Edward Peyton, et al.
BMC Cancer|April 19, 2011
Whole brain radiotherapy after local treatment of brain metastases in melanoma patients--a randomised phase III trialGerald Fogarty, Rachael L Morton, Janette Vardy, et al.
Pediatric Blood & Cancer|February 19, 2010
Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing ProgramPeter J Houghton, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|June 29, 2010
Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing programChristopher L Morton, Peter J Houghton, E Anders Kolb, et al.
Cancer Epidemiology|October 1, 2016
Doctors' recognition and management of melanoma patients' risk: An Australian population-based studyC M Madronio, B K Armstrong, C G Watts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Psychoeducational Intervention to Reduce Fear of Cancer Recurrence in People at High Risk of Developing Another Primary Melanoma: Results of a Randomized Controlled TrialMbathio Dieng, Phyllis N Butow, Daniel S J Costa, et al.
Pageof 111